Skip to content
Screener

Collegium Pharmaceutical, Inc. COLL EBITDA

EBITDA at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$139M+101%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$28.23M+21.9%
Bioventus logo
BioventusBVS
$30.07M-1.1%
Organon logo
OrganonOGN
$363M+40.2%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
-$3.91M-266%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-$3.15M-1.3%

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$944.15M-16.0%
Enterprise value$798.74M-19.5%
P/E19.7×-11.3×
P/S1.2×-0.4×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0×0.0×
Current ratio1×-0.2×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

$3.7Mebit+
$64.8MDepreciation Depletion & Amortization
=$68.46M

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851

FAQ

What is Collegium Pharmaceutical, Inc.'s EBITDA?
Collegium Pharmaceutical, Inc. (COLL) reported EBITDA of $68.46M in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s EBITDA changed year-over-year?
Collegium Pharmaceutical, Inc.'s EBITDA decreased by 25.4% year-over-year, from $91.71M to $68.46M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s EBITDA?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s EBITDA has grown at a 35.8% compound annual growth rate (CAGR), from $86.55M to $294.76M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Collegium Pharmaceutical, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude